SCHEMBL6288960

SCHEMBL6288960

CN1C(=O)C(Cc2ccc(F)c(F)c2)C(=O)c2cc(C(=O)O)oc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.38
HSD17B10 Q99714 4/20 0.38
GAA P10253 2/20 0.38
MAPT P10636 4/20 0.34
KDM4C Q9H3R0 4/20 0.34
L3MBTL1 Q9Y468 4/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
USP2 O75604 2/20 0.33
POLB P06746 2/20 0.33
CACNA1B Q00975 1/20 0.33
APBA1 Q02410 1/20 0.33
THRB P10828 1/20 0.33
RECQL P46063 1/20 0.33
KDM4A O75164 2/20 0.32
CNR1 P21554 2/20 0.32
TSHR P16473 1/20 0.32
CNR2 P34972 1/20 0.32
ALOX15 P16050 1/20 0.32
P2RY14 Q15391 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6289363 0.87 KDM4E (0.43) ALDH1A1HSD17B10MEN1KMT2APOLB
SCHEMBL6289343 0.80 ALDH1A1 (0.34) ALDH1A1HSD17B10GAAMAPTKDM4C
SCHEMBL6289332 0.79 ALDH1A1 (0.34) ALDH1A1HSD17B10GAAMAPTKDM4C
SCHEMBL6680077 0.78 NR1H2 (0.40) ALDH1A1KDM4CPOLBALOX15
SCHEMBL6292698 0.77 ALDH1A1 (0.35) ALDH1A1HSD17B10GAAMAPTKDM4C
SCHEMBL6292798 0.73 PTGER4 (0.40) ALDH1A1HSD17B10GAAMEN1KMT2A
SCHEMBL6289019 0.72 ALDH1A1 (0.35) ALDH1A1HSD17B10GAAMAPTKDM4C
SCHEMBL6292143 0.71 ALDH1A1 (0.34) ALDH1A1HSD17B10GAAL3MBTL1CNR1
SCHEMBL8344071 0.71 MAOB (0.34) ALDH1A1HSD17B10GAAMAPTKDM4C
SCHEMBL6289353 0.71 DAO (0.34) ALDH1A1HSD17B10GAAMAPTKDM4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6949651-B2 Fused bicyclic metalloproteinase inhibitors WARNER-LAMBERT COMPANY (US) 2005-09-27 US disclosed
US-20040034054-A1 Fused bicyclic metalloproteinase inhibitors LINCOLN FOODSERVICE PRODUCTS INC. 2004-02-19 US disclosed
WO-2004014375-A2 FUSED BICYCLIC METALLOPROTEINASE INHIBITORS WARNER-LAMBERT COMPANY LLC (US) 2004-02-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040034054-A1 Fused bicyclic metalloproteinase inhibitors MMP9, MMP1, MMP2 ALDH1A1 337/4885HSD17B10 637/4885GAA 620/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.